Paper41007281
Hypoxia-Driven Extracellular Vesicles Promote Pro-Metastatic Signalling in LNCaP Cells via Wnt and EMT Pathways.
Santos M and 6 others. Biology (Basel), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Hypoxia-Driven Extracellular Vesicles Promote Pro-Metastatic Signalling in LNCaP Cells via Wnt and EMT Pathways. Papers, record 41007281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypoxia-Driven Extracellular Vesicles Promote Pro-Metastatic Signalling in LNCaP Cells via Wnt and EMT Pathways.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| M.S., S.L and PU-O | The Quintin Hogg Trust, and Quality Related (QR) research funding to P U-O. and S.L. from the University of Westminster | PubMed |
Source PubMed
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37546401 | Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. | Front Oncol | 2023 | https://conductscience.org/library/papers/37546401 | PubMed |
| 2 | 33718435 | Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid Biopsy. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33718435 | PubMed |
| 3 | 40647437 | Advances and Challenges in Prostate Cancer Diagnosis: A Comprehensive Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647437 | PubMed |
| 4 | 35798726 | Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35798726 | PubMed |
| 5 | 25721812 | Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. | Semin Cell Dev Biol | 2015 | https://conductscience.org/library/papers/25721812 | PubMed |
| 6 | 24027026 | A molecular signature predictive of indolent prostate cancer. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/24027026 | PubMed |
| 7 | 27279239 | Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment. | Crit Rev Oncog | 2015 | https://conductscience.org/library/papers/27279239 | PubMed |
| 8 | 38491832 | Exosomes in tumor-stroma crosstalk: Shaping the immune microenvironment in colorectal cancer. | FASEB J | 2024 | https://conductscience.org/library/papers/38491832 | PubMed |
| 9 | 39978570 | Extracellular vesicle biomarkers redefine prostate cancer radiotherapy. | Cancer Lett | 2025 | https://conductscience.org/library/papers/39978570 | PubMed |
| 10 | 37070472 | Hypoxia-inducible factor 1A inhibition overcomes castration resistance of prostate tumors. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/37070472 | PubMed |
| 11 | 28486412 | Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28486412 | PubMed |
| 12 | 34209290 | Interplay between Hypoxia and Extracellular Vesicles in Cancer and Inflammation. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34209290 | PubMed |
| 13 | 35163198 | microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163198 | PubMed |
| 14 | 38037077 | The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis. | Mol Cancer | 2023 | https://conductscience.org/library/papers/38037077 | PubMed |
| 15 | 34350796 | Hypoxia and the Tumor Microenvironment. | Technol Cancer Res Treat | 2021 | https://conductscience.org/library/papers/34350796 | PubMed |
| 16 | 36622276 | WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth. | Cancer Res | 2023 | https://conductscience.org/library/papers/36622276 | PubMed |
| 17 | 36100944 | Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. | Mol Cancer | 2022 | https://conductscience.org/library/papers/36100944 | PubMed |
| 18 | 39336161 | Low Magnetic Field Exposure Alters Prostate Cancer Cell Properties. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/39336161 | PubMed |
| 19 | 33920233 | Prostate Cancer Cell Extracellular Vesicles Increase Mineralisation of Bone Osteoblast Precursor Cells in an In Vitro Model. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/33920233 | PubMed |
| 20 | 34656117 | Extracellular vesicles: mediators of intercellular communication in tissue injury and disease. | Cell Commun Signal | 2021 | https://conductscience.org/library/papers/34656117 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42450163 | Oleuropein Attenuates 6-Hydroxydopamine-Induced Cytotoxicity Through Redox Regulation in Differentiated Dopaminergic Neurons: Potential Involvement of RET-Associated Signalling. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450163 |
Source PubMed
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CDH2 | 1000 | PubTator's text mining | https://conductscience.org/library/genes/1000 | NCBI Gene |
| FZD7 | 8324 | PubTator's text mining | https://conductscience.org/library/genes/8324 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
| WNT3A | 89780 | PubTator's text mining | https://conductscience.org/library/genes/89780 | NCBI Gene |
| WNT5A | 7474 | PubTator's text mining | https://conductscience.org/library/genes/7474 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007281
GET https://conductscience.org/api/papers/v1/41007281/references?page=2